People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Pharma, Healthtech, Other Health Care, Software / Tech, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Pear Therapeutics, Inc. | — | Pharma | Series D+ | $254.8M | $4.1B | 2017 |
| Convergent Dental, Inc. | — | Healthtech | Series C | $99.1M | $119.8M | 2023 |
| Fidelis Seniorcare Inc | — | Other Health Care | Series B | $55.1M | $337.9M | 2015 |
| ArborMetrix, Inc. | — | Other Health Care | Series A | $31.2M | $38.4M | 2020 |
| Lucina Health, Inc. | — | Healthtech | Seed | $24.0M | $50.1M | 2009 |
| Tangent Medical Technologies, Inc. | — | Other Health Care | Series A | $23.0M | $20.2M | 2012 |
| Accuri Cytometers Inc | — | Other Health Care | Series A | $9.7M | $121.1M | 2010 |
| NAVV Systems, Inc. | — | Software / Tech | Series A | $9.7M | $9.7M | 2022 |
| Wild Calling Pet Foods, LLC | — | Manufacturing | Seed | $2.2M | $23.7M | 2015 |
Timothy Petersen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Timothy Petersen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey Williams | 2 | 10 |
| Paul McCreadie | 2 | 6 |
| Harry Wilcox | 2 | 6 |
| Timothy B. Petersen | 2 | 5 |
| George Dunbar | 2 | 5 |
| Maria Siambekos | 2 | 2 |
| Timothy Peterson | 2 | 2 |
| Michael Ross | 1 | 18 |
| Andrew Schwab | 1 | 16 |
| Robert Weisskoff | 1 | 12 |
| Wright Steenrod | 1 | 9 |
| Andrew J. Schwab | 1 | 7 |
| William R. Cowen | 1 | 6 |
| WILLIAM COWEN | 1 | 5 |
| Koleman Karleski | 1 | 5 |
| Mark Collins | 1 | 5 |
| Peter Shagory | 1 | 5 |
| Corey McCann | 1 | 5 |
| Elena Viboch | 1 | 4 |
| W. Earl Reed III | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.